What is the latest in myeloproliferative neoplasms (MPNs) from the American Society of Hematology (ASH) annual meeting and what does it mean for patients? MPN expert Dr. Claire Harrison from Guy and St. Thomas Hospital reviews a consolidated list of MPN news which revolves around several studies: PROUD-PV, MPD-RC 112 and the MPN Landmark Study, among others. Dr. Harrison discloses interim results and summarizes the impact on MPN patients. She also shares her predictions for the 2017 meeting including increased understanding of the genetic landscape for patients with MPNs.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo